US Stock MarketDetailed Quotes

TNYA Tenaya Therapeutics

Watchlist
  • 3.760
  • +0.090+2.45%
Trading Jul 23 11:39 ET
295.23MMarket Cap-2278P/E (TTM)

Tenaya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.12%33.76M
4.44%131.19M
-8.98%31.45M
-1.21%30.92M
22.66%35.1M
8.25%33.72M
72.54%125.62M
32.05%34.55M
71.03%31.3M
87.83%28.62M
Selling and administrative expenses
7.26%8.71M
6.66%33.16M
-2.51%8.58M
3.83%7.83M
11.42%8.63M
15.99%8.12M
68.82%31.08M
68.91%8.8M
40.78%7.54M
78.78%7.74M
-General and administrative expense
7.26%8.71M
6.66%33.16M
-2.51%8.58M
3.83%7.83M
11.42%8.63M
15.99%8.12M
68.82%31.08M
68.91%8.8M
40.78%7.54M
78.78%7.74M
Research and development costs
-2.15%25.06M
3.70%98.04M
-11.20%22.87M
-2.81%23.09M
26.83%26.48M
6.00%25.61M
73.80%94.54M
22.88%25.75M
83.54%23.76M
91.42%20.88M
Operating profit
-0.12%-33.76M
-4.44%-131.19M
8.98%-31.45M
1.21%-30.92M
-22.66%-35.1M
-8.25%-33.72M
-72.54%-125.62M
-32.05%-34.55M
-71.03%-31.3M
-87.83%-28.62M
Net non-operating interest income expense
-26.41%1.45M
261.11%7.06M
41.76%1.47M
197.99%1.78M
727.48%1.84M
1,892.93%1.97M
1,709.26%1.95M
1,447.76%1.04M
2,491.30%596K
2,366.67%222K
Non-operating interest income
-26.41%1.45M
261.11%7.06M
41.76%1.47M
197.99%1.78M
727.48%1.84M
1,892.93%1.97M
1,709.26%1.95M
1,447.76%1.04M
2,491.30%596K
2,366.67%222K
Other net income (expense)
530.77%82K
2,550.00%53K
1,466.67%41K
-83.33%1K
-2K
1,400.00%13K
108.70%2K
94.44%-3K
-60.00%6K
Other non- operating income (expenses)
530.77%82K
2,550.00%53K
1,466.67%41K
-83.33%1K
---2K
1,400.00%13K
108.70%2K
94.44%-3K
-60.00%6K
----
Income before tax
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
-68.09%-30.7M
-86.70%-28.4M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
-68.09%-30.7M
-86.70%-28.4M
Net income continuous Operations
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
-68.09%-30.7M
-86.70%-28.4M
Minority interest income
Net income attributable to the parent company
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
-68.09%-30.7M
-86.70%-28.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
-68.09%-30.7M
-86.70%-28.4M
Basic earnings per share
6.98%-0.4
39.13%-1.68
34.43%-0.4
47.30%-0.39
34.78%-0.45
42.67%-0.43
32.68%-2.76
3.17%-0.61
-8.82%-0.74
-69.32%-0.69
Diluted earnings per share
6.98%-0.4
39.13%-1.68
34.43%-0.4
47.30%-0.39
34.78%-0.45
42.67%-0.43
32.68%-2.76
3.17%-0.61
-8.82%-0.74
-69.32%-0.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.12%33.76M4.44%131.19M-8.98%31.45M-1.21%30.92M22.66%35.1M8.25%33.72M72.54%125.62M32.05%34.55M71.03%31.3M87.83%28.62M
Selling and administrative expenses 7.26%8.71M6.66%33.16M-2.51%8.58M3.83%7.83M11.42%8.63M15.99%8.12M68.82%31.08M68.91%8.8M40.78%7.54M78.78%7.74M
-General and administrative expense 7.26%8.71M6.66%33.16M-2.51%8.58M3.83%7.83M11.42%8.63M15.99%8.12M68.82%31.08M68.91%8.8M40.78%7.54M78.78%7.74M
Research and development costs -2.15%25.06M3.70%98.04M-11.20%22.87M-2.81%23.09M26.83%26.48M6.00%25.61M73.80%94.54M22.88%25.75M83.54%23.76M91.42%20.88M
Operating profit -0.12%-33.76M-4.44%-131.19M8.98%-31.45M1.21%-30.92M-22.66%-35.1M-8.25%-33.72M-72.54%-125.62M-32.05%-34.55M-71.03%-31.3M-87.83%-28.62M
Net non-operating interest income expense -26.41%1.45M261.11%7.06M41.76%1.47M197.99%1.78M727.48%1.84M1,892.93%1.97M1,709.26%1.95M1,447.76%1.04M2,491.30%596K2,366.67%222K
Non-operating interest income -26.41%1.45M261.11%7.06M41.76%1.47M197.99%1.78M727.48%1.84M1,892.93%1.97M1,709.26%1.95M1,447.76%1.04M2,491.30%596K2,366.67%222K
Other net income (expense) 530.77%82K2,550.00%53K1,466.67%41K-83.33%1K-2K1,400.00%13K108.70%2K94.44%-3K-60.00%6K
Other non- operating income (expenses) 530.77%82K2,550.00%53K1,466.67%41K-83.33%1K---2K1,400.00%13K108.70%2K94.44%-3K-60.00%6K----
Income before tax -1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M-68.09%-30.7M-86.70%-28.4M
Income tax 0000000000
Net income -1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M-68.09%-30.7M-86.70%-28.4M
Net income continuous Operations -1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M-68.09%-30.7M-86.70%-28.4M
Minority interest income
Net income attributable to the parent company -1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M-68.09%-30.7M-86.70%-28.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M-68.09%-30.7M-86.70%-28.4M
Basic earnings per share 6.98%-0.439.13%-1.6834.43%-0.447.30%-0.3934.78%-0.4542.67%-0.4332.68%-2.763.17%-0.61-8.82%-0.74-69.32%-0.69
Diluted earnings per share 6.98%-0.439.13%-1.6834.43%-0.447.30%-0.3934.78%-0.4542.67%-0.4332.68%-2.763.17%-0.61-8.82%-0.74-69.32%-0.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg